Catheter Precision Surges 53% on UK Approval for LockeT Device
Catheter Precision, Inc. (VTAK) jumped 52.84% to lead the PRISM Emerging MedDevices Index after securing regulatory approval in the United Kingdom for its LockeT™ suture retention device. This follows CE Mark clearance in May and enables immediate commercial launch across the UK. The company partnered with HC21, a leading distributor with €180M in annual revenue, to expand market reach. Management highlighted LockeT’s potential to improve efficiency in wound closure after cardiac procedures, supporting NHS efforts to reduce hospital waiting lists and accelerate patient throughput.
Enlivex Drops 18% Despite Positive Phase IIa Data in Knee Osteoarthritis
Shares of Enlivex Therapeutics Ltd. (ENLV) declined 18.14%, dragging the PRISM Emerging Biotech Indexlower, despite reporting positive topline results from a Phase I/II trial of Allocetra in knee osteoarthritis. Patients showed a 24% reduction in pain and 26% improvement in knee function compared to placebo, with even stronger benefits in age-related primary osteoarthritis patients. Allocetra also demonstrated a favorable safety profile.
Other PRISM Mid-Day Movers:
- Tonix Pharmaceuticals (TNXP) fell 22.06%
- Applied Digital (APLD) gained 14.30%
- BioXcel Therapeutics (BTAI) rose 15.31%
The post PRISM Mid-Day Movers: UK Regulatory Approvals and Positive Data Diverge Indices appeared first on PRISM MarketView.